Literature DB >> 15743185

Cationic polysaccharides as antiprion agents.

Ira Yudovin-Farber1, Tony Azzam, Esther Metzer, Albert Taraboulos, Abraham J Domb.   

Abstract

Cationic polysaccharides were synthesized by conjugation of various oligoamines to oxidized polysaccharides by reductive amination and tested for antiprion activity. Polycations of dextran, pullulan and arabinogalactan grafted with oligoamines of 2 to 4 amino groups were investigated for their ability to eliminate PrP(Sc), the protease-resistant isoform of the prion protein, from chronically infected neuroblastoma cells, ScN2a-M. The proteinase K (PK)-resistant PrP elimination depends on both the concentration of the reagent and the duration of exposure. The most potent compound was found to be dextran-spermine that caused depletion of PrP(Sc) to undetectable levels at concentration of 31 ng/mL after 4 days of exposure. Activity analysis revealed that grafted oligoamine indentity of the polycation plays a significant role in elimination of PK-resistant PrP from chronically infected N2a-M cells, regardless of the polysaccharide used. Dextran-spermine conjugates were modified with oleic acid and with methoxypoly(ethylene glycol) (MPEG) at various degrees of substitution for further studies and their antiprion activity was examined. Substitution of dextran-spermine with MPEG or oleic acid slightly decreases its activity as a function of MPEG/oleic acid content. These findings confirm previous reports that polycations are effective in eliminating PrP(Sc) in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743185     DOI: 10.1021/jm049378o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.

Authors:  N C Ferreira; L M Ascari; A G Hughson; G R Cavalheiro; C F Góes; P N Fernandes; J R Hollister; R A da Conceição; D S Silva; A M T Souza; M L C Barbosa; F A Lara; R A P Martins; B Caughey; Y Cordeiro
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

2.  Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.

Authors:  O Kovalchuk Ben-Zaken; I Nissan; S Tzaban; A Taraboulos; E Zcharia; S Matzger; I Shafat; I Vlodavsky; Y Tal
Journal:  Biochem Biophys Res Commun       Date:  2015-07-10       Impact factor: 3.575

3.  2-Aminothiazoles as therapeutic leads for prion diseases.

Authors:  Alejandra Gallardo-Godoy; Joel Gever; Kimberly L Fife; B Michael Silber; Stanley B Prusiner; Adam R Renslo
Journal:  J Med Chem       Date:  2011-01-19       Impact factor: 7.446

Review 4.  Complex polyamines: unique prion disaggregating compounds.

Authors:  Surachai Supattapone; Justin R Piro; Judy R Rees
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

5.  Inhibition of PrP(Sc) formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives.

Authors:  Fani Koukouli; Ioannis Paspaltsis; Evgenia Salta; Konstantinos Xanthopoulos; Eftychia N Koini; Theodora Calogeropoulou; Theodoros Sklaviadis
Journal:  Prion       Date:  2012-08-23       Impact factor: 3.931

6.  Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.

Authors:  B Michael Silber; Joel R Gever; Zhe Li; Alejandra Gallardo-Godoy; Adam R Renslo; Kartika Widjaja; John J Irwin; Satish Rao; Matthew P Jacobson; Sina Ghaemmaghami; Stanley B Prusiner
Journal:  Bioorg Med Chem       Date:  2013-09-18       Impact factor: 3.641

7.  QSAR study of anti-prion activity of 2-aminothiazoles.

Authors:  Prasit Mandi; Chanin Nantasenamat; Kakanand Srungboonmee; Chartchalerm Isarankura-Na-Ayudhya; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2012-08-15       Impact factor: 4.068

8.  Constructing Biopolymer-Inorganic Nanocomposite through a Biomimetic Mineralization Process for Enzyme Immobilization.

Authors:  Jian Li; Jun Ma; Tao Jiang; Yanhuan Wang; Xuemei Wen; Guozhu Li
Journal:  Materials (Basel)       Date:  2015-09-09       Impact factor: 3.623

9.  Discovery of Novel Anti-prion Compounds Using In Silico and In Vitro Approaches.

Authors:  Jae Wook Hyeon; Jiwon Choi; Su Yeon Kim; Rajiv Gandhi Govindaraj; Kyu Jam Hwang; Yeong Seon Lee; Seong Soo A An; Myung Koo Lee; Jong Young Joung; Kyoung Tai No; Jeongmin Lee
Journal:  Sci Rep       Date:  2015-10-09       Impact factor: 4.379

Review 10.  Bioactive polysaccharides from natural resources including Chinese medicinal herbs on tissue repair.

Authors:  Qiu Li; Yiming Niu; Panfei Xing; Chunming Wang
Journal:  Chin Med       Date:  2018-02-06       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.